Peng Cui

951 total citations
13 papers, 268 citations indexed

About

Peng Cui is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Peng Cui has authored 13 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Peng Cui's work include Cancer-related molecular mechanisms research (4 papers), RNA modifications and cancer (3 papers) and Circular RNAs in diseases (3 papers). Peng Cui is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), RNA modifications and cancer (3 papers) and Circular RNAs in diseases (3 papers). Peng Cui collaborates with scholars based in China, United States and Netherlands. Peng Cui's co-authors include Baohua Hou, Shaojie Li, Zhixiang Jian, Yu Xu, Zhu Xin, Shangli Cai, Jia Fan, Qiang Zeng, Zhijie Wang and Chengcheng Li and has published in prestigious journals such as FEBS Letters, Molecular Pharmacology and BioMed Research International.

In The Last Decade

Peng Cui

11 papers receiving 265 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peng Cui China 9 179 175 41 27 20 13 268
Haitao Zhang China 11 172 1.0× 221 1.3× 53 1.3× 30 1.1× 23 1.1× 25 340
Jitao Zhou China 8 183 1.0× 219 1.3× 77 1.9× 44 1.6× 35 1.8× 16 345
Callie R. Merry United States 8 252 1.4× 330 1.9× 60 1.5× 21 0.8× 11 0.6× 8 383
Shiyin Ma China 9 225 1.3× 252 1.4× 32 0.8× 28 1.0× 16 0.8× 23 321
Weidong Wen China 6 119 0.7× 147 0.8× 29 0.7× 42 1.6× 13 0.7× 9 259
Д. С. Ходырев Russia 13 205 1.1× 301 1.7× 34 0.8× 32 1.2× 13 0.7× 48 375

Countries citing papers authored by Peng Cui

Since Specialization
Citations

This map shows the geographic impact of Peng Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Cui more than expected).

Fields of papers citing papers by Peng Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Cui. The network helps show where Peng Cui may publish in the future.

Co-authorship network of co-authors of Peng Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Cui. A scholar is included among the top collaborators of Peng Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Cui. Peng Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Liu, Zhichao, Guoqiang Wang, Yang Yang, et al.. (2025). ctDNA detects residual disease after neoadjuvant chemoradiotherapy and guides adjuvant therapy in esophageal squamous cell carcinoma. Cell Reports Medicine. 6(9). 102334–102334.
2.
Liu, Hongbo, Bingxin Zhang, Qingyang Li, et al.. (2024). The functional divergence of homologous GPAT9 genes contributes to the erucic acid content of Brassica napus seeds. BMC Plant Biology. 24(1). 69–69. 6 indexed citations
3.
Zhang, Xueqin, et al.. (2023). 横断山地区气候<bold>-</bold>植被区划. SCIENTIA SINICA Terrae.
4.
Min, Zhijun, et al.. (2022). Long Non-Coding RNA CKMT2-AS1 Reduces the Viability of Colo-rectal Cancer Cells by Targeting AKT/mTOR Signaling Pathway. Iranian Journal of Public Health. 51(2). 327–335. 12 indexed citations
5.
Gao, Qiang, Qiang Zeng, Zhijie Wang, et al.. (2022). Circulating cell-free DNA for cancer early detection. The Innovation. 3(4). 100259–100259. 97 indexed citations
6.
Cui, Peng, et al.. (2019). <p>LncRNA RHPN1-AS1 Targeting miR-625/REG3A Promotes Cell Proliferation And Invasion Of Glioma Cells</p>. OncoTargets and Therapy. Volume 12. 7911–7921. 20 indexed citations
7.
Li, Jing, Jiajia Xu, Fei Xiao, et al.. (2019). MiR-144 Inhibits Tumor Growth and Metastasis in Osteosarcoma via Dual-suppressing RhoA/ROCK1 Signaling Pathway. Molecular Pharmacology. 95(4). 451–461. 22 indexed citations
8.
Cui, Peng, Zhuo Wang, Tao Wang, et al.. (2017). Identification of human circadian genes based on time course gene expression profiles by using a deep learning method. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(6). 2274–2283. 16 indexed citations
9.
Chen, Lei, Lingling Sun, Lei Dong, et al.. (2017). The role of long noncoding RNA-LET in cell proliferation and invasion of nasopharyngeal carcinoma and its mechanism. OncoTargets and Therapy. Volume 10. 2769–2778. 14 indexed citations
10.
Liu, Cheng‐Lin, Peng Cui, & Tao Huang. (2017). Identification of Cell Cycle-Regulated Genes by Convolutional Neural Network. Combinatorial Chemistry & High Throughput Screening. 20(7). 603–611. 9 indexed citations
11.
Hou, Baohua, et al.. (2015). miR‐216a may inhibit pancreatic tumor growth by targeting JAK2. FEBS Letters. 589(17). 2224–2232. 57 indexed citations
12.
Sun, Bo, Menghuan Zhang, Peng Cui, et al.. (2015). Nonsynonymous Single-Nucleotide Variations on Some Posttranslational Modifications of Human Proteins and the Association with Diseases. Computational and Mathematical Methods in Medicine. 2015. 1–12. 6 indexed citations
13.
Cui, Peng, Jing Li, Bo Sun, et al.. (2013). A Quantitative Analysis of the Impact on Chromatin Accessibility by Histone Modifications and Binding of Transcription Factors in DNase I Hypersensitive Sites. BioMed Research International. 2013. 1–7. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026